A rare disease is generally defined as a condition that affects a very small proportion of the population. However, global experts are now expanding this definition beyond numbers alone.

Frederick, MD — Gov. Wes Moore on Friday announced that AstraZeneca will invest $2 billion to expand its operations in Maryland in what he described as the “single largest private investment in ...

DEVELOPMENTS FROM FREDERICK. THE INVESTMENT PROVIDES AN ECONOMIC SHOT IN THE ARM, CREATES JOBS AND BOOSTS THE STATE’S EFFORT TO EXPAND MARYLAND’S LIFE SCIENCES SECTOR. TODAY IS ABOUT SHOWING THAT WE ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces plans to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This includes a significant expansion of its ...

This is read by an automated voice. Please report any issues or inconsistencies here. AstraZeneca becomes second major pharmaceutical company to agree to lower Medicaid drug prices under Trump ...

President Donald Trump announced on Friday a deal with drugmaker AstraZeneca in his latest effort to lower drug costs through so-called “Most Favored Nation” pricing. The move comes after the ...

AstraZeneca will build a $4.5 billion manufacturing facility in Albemarle County, Virginia. The new plant is expected to create approximately 3,600 jobs in the region. The facility will produce drugs ...

Gov. Glenn Youngkin announced Thursday that global pharmaceutical manufacturer and biotech company AstraZeneca will invest $4.5 billion to establish two new manufacturing facilities in Albemarle ...

AstraZeneca has signed a $555 million deal with San Francisco biotech Algen Biotechnologies that will tap the latter company’s artificial intelligence platform to boost discovery of new targets in ...

AstraZeneca shares rallied on Wednesday after the U.K.-based pharmaceuticals giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.

AstraZeneca is the latest Big Pharma to unveil a digital direct-to-consumer platform offering certain medicines at heavily reduced prices to cash-pay patients. AstraZeneca Direct will go live Oct. 1, ...

AstraZeneca has asked the Supreme Court to hear its case challenging the Medicare Drug Price Negotiation Program created through the Inflation Reduction Act (IRA). According to the Supreme Court’s ...